A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes Post author:Annie Holland Post published:February 18, 2025 Post category:News Feed Post comments:0 Comments New research shows sotagliflozin is the only drug in its class to demonstrate these results. You Might Also Like Researchers use AI to help people see more clearly October 2, 2024 CRISPR-Cas technology: Balancing efficiency and safety December 5, 2024 Novel calculator predicts risk of epilepsy after rare stroke November 13, 2024 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.